Hirano, Ikuo; Dellon, Evan S; Falk, Gary W; Gonsalves, Nirmala P; Furuta, Glenn T; Bredenoord, Albert J (2024). Ascending to new heights for novel therapeutics for eosinophilic esophagitis. Gastroenterology, 166(1), pp. 1-10. Elsevier 10.1053/j.gastro.2023.09.004
|
Text
1-s2.0-S001650852304979X-main.pdf - Accepted Version Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND). Download (733kB) | Preview |
|
![[img]](https://boris.unibe.ch/style/images/fileicons/text.png) |
Text
Hirano_Gastroenterology_2024.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (679kB) |
Item Type: |
Journal Article (Further Contribution) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Social and Preventive Medicine (ISPM) |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
0016-5085 |
Publisher: |
Elsevier |
Language: |
English |
Submitter: |
Pubmed Import |
Date Deposited: |
12 Sep 2023 10:04 |
Last Modified: |
11 Sep 2024 00:25 |
Publisher DOI: |
10.1053/j.gastro.2023.09.004 |
PubMed ID: |
37690772 |
Additional Information: |
Ekaterina Safroneeva participated in the 'Assessment of Clinical endpoints in Eosinophilic esophagitis for Novel Therapeutics (ASCENT) working group'. |
Uncontrolled Keywords: |
Eosinophilic esophagitis clinical trial design eosinophil esophagitis |
BORIS DOI: |
10.48350/186211 |
URI: |
https://boris.unibe.ch/id/eprint/186211 |
Actions (login required)
 |
Edit item |